Ligand Pharmaceuticals, Inc.
USD0.00
+0.00 (+19.23%)
CEO
Todd C. Davis
IPO Date
2022-11-01
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.00
Market Cap
$0.00B
Volume
0.00M
| -486.1 |
| 31 Dec 2023 | FY | 73.3% | 39.7% | 7.4% | 6.6% | 0.01 | 14.15 | 23.7 |
| 31 Dec 2022 | FY | 73.1% | -17.0% | -5.6% | -4.4% | 0.15 | 2.67 | -33.8 |
| 31 Dec 2021 | FY | 74.3% | 23.7% | 7.0% | 4.4% | 0.40 | 11.15 | 28.0 |
| 31 Dec 2020 | FY | 81.4% | -1.8% | -0.4% | -0.2% | 0.64 | 5.00 | -336.4 |
| 31 Dec 2019 | FY | 90.6% | 523.2% | 82.0% | 42.1% | 0.85 | 66.09 | 2.0 |
| 31 Dec 2018 | FY | 97.5% | 57.0% | 25.6% | 11.4% | 1.13 | 10.58 | 14.2 |
| 31 Dec 2017 | FY | 96.2% | 8.9% | 3.0% | 1.9% | 0.54 | 0.99 | 143.1 |
| 31 Dec 2016 | FY | 94.9% | -1.5% | -0.4% | -0.3% | 0.57 | 0.72 | -807.1 |
| 20.8 |
| 30 Sept 2025 | Q3 | 78.5% | 101.6% | 12.3% | 7.9% | 0.47 | 24.69 | 7.3 |
| 30 Jun 2025 | Q2 | 93.9% | 10.2% | 0.6% | 0.5% | 0.01 | 5.45 | 113.3 |
| 31 Mar 2025 | Q1 | 89.3% | -93.6% | -5.3% | -4.7% | 0.01 | 5.27 | -11.9 |
| 31 Dec 2024 | Q4 | 93.4% | -72.6% | -3.7% | -3.3% | 0.01 | 8.93 | -16.3 |
| 30 Sept 2024 | Q3 | 75.9% | -13.8% | -0.9% | -0.8% | 0.01 | 12.49 | -64.3 |
| 30 Jun 2024 | Q2 | 136.9% | -125.0% | -6.7% | -6.0% | 0.01 | 16.82 | -7.4 |
| 31 Mar 2024 | Q1 | 64.3% | 278.1% | 10.7% | 9.4% | 0.01 | 20.70 | 3.8 |
| 31 Dec 2023 | Q4 | 94.1% | 64.7% | 2.6% | 2.3% | 0.01 | 14.15 | 17.1 |